• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

雌激素受体β基因启动子中rs1271572的意义及其与中国西南地区人群乳腺癌的相关性

Significance of rs1271572 in the estrogen receptor beta gene promoter and its correlation with breast cancer in a southwestern Chinese population.

作者信息

Chen Li, Liang Yan, Qiu Juhui, Zhang Lingling, Chen Xianchun, Luo Xiangdong, Jiang Jun

出版信息

J Biomed Sci. 2013 May 28;20(1):32. doi: 10.1186/1423-0127-20-32.

DOI:10.1186/1423-0127-20-32
PMID:23711151
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3672062/
Abstract

BACKGROUND

To characterize single nucleotide polymorphisms (SNPs) within the promoter region of the estrogen receptor beta (ERβ) gene and to analyze the association of ERβ SNPs with susceptibility to breast cancer. Genotype frequencies of five SNPs (rs3020449, rs3020450, rs2987983, rs1271572 and rs1887994) in the promoter region of the ERβ gene in 873 women with breast cancer, 645 women with fibroadenoma and 700 healthy women were determined using an allele-specific tetra-primer polymerase chain reaction (PCR). Kaplan-Meier survival analysis was performed to evaluate the association of selected rs1271572 with prognosis in breast cancer. Electrophoretic mobility-shift assays were conducted to explore the binding of SNP rs1271572 containing probes to transcriptional factor Ying Yang 1 (YY1).

RESULTS

Women with the homozygous TT genotype of rs1271572 had a significantly higher risk in developing breast cancer. Breast cancer patients with the TT genotype of rs1271572 had lower five-year survival rates than those with other genotypes and were more likely to suffer brain metastases. The rs1271572 G→T SNP abrogated YY1 binding and reduced the transcription activity of the promoter 0 N in the ERβ gene in vitro.

CONCLUSIONS

TT genotype of rs1271572 is associated with increased risk for breast cancer in Chinese women and is associated with unfavored prognosis in Chinese breast cancer patients. TT genotype of rs1271572 inhibited expression of ERβ gene by down regulating transcriptional activity of the promoter 0 N in the ERβ gene. Our data revealed that the TT genotype of rs1271572 resulted in loss of the YY1 binding site and reduced the transcription activity of the promoter 0 N in the ERβ gene.

摘要

背景

对雌激素受体β(ERβ)基因启动子区域内的单核苷酸多态性(SNP)进行特征分析,并分析ERβ SNP与乳腺癌易感性之间的关联。采用等位基因特异性四引物聚合酶链反应(PCR)测定了873例乳腺癌女性、645例纤维腺瘤女性和700例健康女性中ERβ基因启动子区域5个SNP(rs3020449、rs3020450、rs2987983、rs1271572和rs1887994)的基因型频率。进行Kaplan-Meier生存分析以评估所选rs1271572与乳腺癌预后的关联。进行电泳迁移率变动分析以探究含SNP rs1271572的探针与转录因子阴阳1(YY1)的结合情况。

结果

rs1271572纯合TT基因型的女性患乳腺癌的风险显著更高。rs1271572 TT基因型的乳腺癌患者的五年生存率低于其他基因型患者,且更易发生脑转移。rs1271572 G→T SNP消除了YY1的结合,并在体外降低了ERβ基因启动子0 N的转录活性。

结论

rs1271572的TT基因型与中国女性患乳腺癌风险增加相关,且与中国乳腺癌患者的不良预后相关。rs1271572的TT基因型通过下调ERβ基因启动子0 N的转录活性抑制ERβ基因的表达。我们的数据显示,rs1271572的TT基因型导致YY1结合位点缺失,并降低了ERβ基因启动子0 N的转录活性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bfe8/3672062/a068e5933dca/1423-0127-20-32-6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bfe8/3672062/05449d69e98d/1423-0127-20-32-1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bfe8/3672062/9aa76c9ade8e/1423-0127-20-32-2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bfe8/3672062/433a2ad13b9d/1423-0127-20-32-3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bfe8/3672062/8d7a0d114f25/1423-0127-20-32-4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bfe8/3672062/602a9a3429af/1423-0127-20-32-5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bfe8/3672062/a068e5933dca/1423-0127-20-32-6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bfe8/3672062/05449d69e98d/1423-0127-20-32-1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bfe8/3672062/9aa76c9ade8e/1423-0127-20-32-2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bfe8/3672062/433a2ad13b9d/1423-0127-20-32-3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bfe8/3672062/8d7a0d114f25/1423-0127-20-32-4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bfe8/3672062/602a9a3429af/1423-0127-20-32-5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bfe8/3672062/a068e5933dca/1423-0127-20-32-6.jpg

相似文献

1
Significance of rs1271572 in the estrogen receptor beta gene promoter and its correlation with breast cancer in a southwestern Chinese population.雌激素受体β基因启动子中rs1271572的意义及其与中国西南地区人群乳腺癌的相关性
J Biomed Sci. 2013 May 28;20(1):32. doi: 10.1186/1423-0127-20-32.
2
Polymorphisms in the promoter region of ESR2 gene and breast cancer susceptibility.雌激素受体2(ESR2)基因启动子区域多态性与乳腺癌易感性
J Steroid Biochem Mol Biol. 2009 Apr;114(3-5):207-11. doi: 10.1016/j.jsbmb.2009.02.012. Epub 2009 Mar 3.
3
[Association between single-nucleotide polymorphisms in estrogen receptor beta gene and risk of prostate cancer].雌激素受体β基因单核苷酸多态性与前列腺癌风险的关联
Zhonghua Wai Ke Za Zhi. 2005 Jul 15;43(14):948-51.
4
Polymorphisms in the promoter region of ESR2 gene and susceptibility to ovarian cancer.雌激素受体2(ESR2)基因启动子区域多态性与卵巢癌易感性
Gene. 2014 Aug 10;546(2):283-7. doi: 10.1016/j.gene.2014.05.066. Epub 2014 Jun 2.
5
Polymorphisms in the promoter region of estrogen receptor β gene in endometrial cancer.雌激素受体β基因启动子区多态性与子宫内膜癌。
Arch Gynecol Obstet. 2014 Mar;289(3):631-5. doi: 10.1007/s00404-013-3012-8. Epub 2013 Aug 24.
6
Estrogen receptor beta polymorphism is associated with prostate cancer risk.雌激素受体β多态性与前列腺癌风险相关。
Clin Cancer Res. 2006 Mar 15;12(6):1936-41. doi: 10.1158/1078-0432.CCR-05-0269.
7
Estrogen receptor beta gene polymorphisms and susceptibility to uterine fibroids.雌激素受体β基因多态性与子宫肌瘤易感性。
Gynecol Endocrinol. 2010 Jan;26(1):4-9. doi: 10.3109/09513590903159573.
8
Genetic polymorphisms in the estrogen receptor beta (ESR2) gene and the risk of epithelial ovarian carcinoma.雌激素受体β(ESR2)基因的遗传多态性与上皮性卵巢癌风险
Cancer Causes Control. 2009 Feb;20(1):47-55. doi: 10.1007/s10552-008-9216-8. Epub 2008 Aug 15.
9
Clinical significance of promoter hypermethylation of ERβ and RARβ2 in tumor and serum DNA in Indian breast cancer patients.印度乳腺癌患者肿瘤和血清 DNA 中 ERβ 和 RARβ2 启动子高甲基化的临床意义。
Ann Surg Oncol. 2012 Sep;19(9):3107-15. doi: 10.1245/s10434-012-2323-5. Epub 2012 Mar 27.
10
A genetic variant in p63 (rs17506395) is associated with breast cancer susceptibility and prognosis.p63 基因中的一个遗传变异(rs17506395)与乳腺癌易感性和预后相关。
Gene. 2014 Feb 10;535(2):170-6. doi: 10.1016/j.gene.2013.11.038. Epub 2013 Dec 4.

引用本文的文献

1
Hidden secrets of the cancer genome: unlocking the impact of non-coding mutations in gene regulatory elements.癌症基因组的隐藏秘密:揭示基因调控元件中非编码突变的影响。
Cell Mol Life Sci. 2024 Jun 20;81(1):274. doi: 10.1007/s00018-024-05314-z.
2
Association between estrogen receptor β polymorphisms and prostate cancer in a Slovak population.斯洛伐克人群中雌激素受体β基因多态性与前列腺癌的关联。
Oncol Lett. 2021 Mar;21(3):214. doi: 10.3892/ol.2021.12475. Epub 2021 Jan 19.
3
The role of estrogen receptor beta in breast cancer.雌激素受体β在乳腺癌中的作用。

本文引用的文献

1
Yin Yang 1 plays an essential role in breast cancer and negatively regulates p27.阴阳 1 在乳腺癌中发挥着重要作用,并负调控 p27。
Am J Pathol. 2012 May;180(5):2120-33. doi: 10.1016/j.ajpath.2012.01.037. Epub 2012 Mar 20.
2
Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008.2008 年全球癌症负担估计值:GLOBOCAN 2008。
Int J Cancer. 2010 Dec 15;127(12):2893-917. doi: 10.1002/ijc.25516.
3
A systematic review of the relationship between polymorphic sites in the estrogen receptor-beta (ESR2) gene and breast cancer risk.
Biomark Res. 2020 Sep 7;8:39. doi: 10.1186/s40364-020-00223-2. eCollection 2020.
4
Association of the polymorphisms of the genes APOC3 (rs2854116), ESR2 (rs3020450), HFE (rs1799945), MMP1 (rs1799750) and PPARG (rs1801282) with lipodystrophy in people living with HIV on antiretroviral therapy: a systematic review.载脂蛋白 C3(rs2854116)、雌激素受体 2(rs3020450)、HFE(rs1799945)、基质金属蛋白酶 1(rs1799750)和过氧化物酶体增殖物激活受体 γ(rs1801282)基因多态性与接受抗逆转录病毒治疗的 HIV 感染者脂肪营养不良的相关性:系统评价。
Mol Biol Rep. 2020 Jun;47(6):4779-4787. doi: 10.1007/s11033-020-05441-3. Epub 2020 Apr 22.
5
Impact of Genetic Variants in Estrogen Receptor-β Gene in the Etiology of Uterine Leiomyomas.雌激素受体-β基因的遗传变异在子宫肌瘤病因学中的作用
J Reprod Infertil. 2019 Jul-Sep;20(3):151-160.
6
Genetic polymorphisms of estrogen receptor genes are associated with breast cancer susceptibility in Chinese women.雌激素受体基因的遗传多态性与中国女性患乳腺癌的易感性相关。
Cancer Cell Int. 2019 Jan 8;19:11. doi: 10.1186/s12935-019-0727-z. eCollection 2019.
7
Polymorphisms in sex steroid receptors: From gene sequence to behavior.性甾体受体的多态性:从基因序列到行为。
Front Neuroendocrinol. 2017 Oct;47:47-65. doi: 10.1016/j.yfrne.2017.07.003. Epub 2017 Jul 10.
8
Social memory associated with estrogen receptor polymorphisms in women.女性中与雌激素受体多态性相关的社会记忆。
Soc Cogn Affect Neurosci. 2016 Jun;11(6):877-83. doi: 10.1093/scan/nsw010. Epub 2016 Mar 8.
9
Estrogen receptor-beta genetic variations and overall survival in patients with locally advanced gastric cancer.雌激素受体-β基因变异与局部晚期胃癌患者的总生存期
Pharmacogenomics J. 2017 Jan;17(1):36-41. doi: 10.1038/tpj.2015.77. Epub 2015 Oct 27.
10
Human Genes Encoding Transcription Factors and Chromatin-Modifying Proteins Have Low Levels of Promoter Polymorphism: A Study of 1000 Genomes Project Data.编码转录因子和染色质修饰蛋白的人类基因具有低水平的启动子多态性:一项基于千人基因组计划数据的研究。
Int J Genomics. 2015;2015:260159. doi: 10.1155/2015/260159. Epub 2015 Aug 31.
雌激素受体-β(ESR2)基因多态性位点与乳腺癌风险关系的系统评价。
Breast Cancer Res Treat. 2011 Feb;126(1):37-45. doi: 10.1007/s10549-010-0891-2.
4
Combinatorial biomarker expression in breast cancer.乳腺癌的组合生物标志物表达。
Breast Cancer Res Treat. 2010 Apr;120(2):293-308. doi: 10.1007/s10549-010-0746-x. Epub 2010 Jan 28.
5
Representativeness of population-based cancer registration in China--comparison of urban and rural areas.中国基于人群的癌症登记的代表性——城乡比较。
Asian Pac J Cancer Prev. 2009 Oct-Dec;10(4):559-64.
6
Expression of estrogen receptor beta increases integrin alpha1 and integrin beta1 levels and enhances adhesion of breast cancer cells.雌激素受体β的表达增加整合素α1和整合素β1的水平,并增强乳腺癌细胞的黏附。
J Cell Physiol. 2010 Jan;222(1):156-67. doi: 10.1002/jcp.21932.
7
Polymorphisms in genes of the steroid receptor superfamily modify postmenopausal breast cancer risk associated with menopausal hormone therapy.甾体激素受体超家族基因多态性改变与绝经后激素治疗相关的绝经后乳腺癌风险。
Int J Cancer. 2010 Jun 15;126(12):2935-46. doi: 10.1002/ijc.24892.
8
YY1 is autoregulated through its own DNA-binding sites.YY1 通过其自身的 DNA 结合位点进行自我调节。
BMC Mol Biol. 2009 Aug 27;10:85. doi: 10.1186/1471-2199-10-85.
9
Estrogen receptor polymorphisms: significance to human physiology, disease and therapy.雌激素受体多态性:对人体生理学、疾病及治疗的意义。
Recent Pat DNA Gene Seq. 2009;3(3):164-71. doi: 10.2174/187221509789318397.
10
Estrogen receptor beta gene polymorphisms and susceptibility to uterine fibroids.雌激素受体β基因多态性与子宫肌瘤易感性。
Gynecol Endocrinol. 2010 Jan;26(1):4-9. doi: 10.3109/09513590903159573.